A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis
Clinical trial NCT03546985 · COMPLETED
Trial details
- NCT number
- NCT03546985
- Sponsor
- Solasia Pharma K.K.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-26
- Primary completion
- 2018-05-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.